About Zinc finger protein 675
Zinc finger protein 675 (ZNF675) is a protein
from Homo sapiens identified by UniProt accession
Q8TD23, 568 residues long.
MolForge cross-references it against 0 known binders and
26 disease associations.
Target properties
| Protein name | Zinc finger protein 675 |
| UniProt accession | Q8TD23 |
| Gene | ZNF675 |
| Organism | Homo sapiens |
| Length | 568 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (26)
Diseases linked to this target (Open Targets).
- cortical surface area measurement · score 0.41
- brain measurement · score 0.32
- Testicular Germ Cell Tumor · score 0.28
- blood protein measurement · score 0.22
- upper extremity fracture · score 0.07
- glioblastoma multiforme · score 0.03
- osteosarcoma · score 0.02
- psoriasis · score 0.02
- infection · score 0.02
- infect · score 0.02
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q8TD23-F1 | alphafold | PREDICTED | 71.98 | — |
Amino-acid sequence (568 residues)
MGLLTFRDVA IEFSLEEWQC LDTAQRNLYK NVILENYRNL VFLGIAVSKQ DLITCLEQEK EPLTVKRHEM VNEPPVMCSH FAQEFWPEQN IKDSFEKVTL RRYEKCGNDN FQLKGCKSVD ECKLHKGGYN GLNQCLPTMQ SKMFQCDKYV KVFNKFSHSD RHKIKHMENK PFKCKECGRS FCMLSHLTRH ERNYTKVNFC KCEECEKAVN QSSKLTKHKR IYTCEKLYKC QECDRTFNQF SNLTEYKKDY AREKPYKCEE CGKAFNQSSH LTTHKIIHTG EKPYKCEECG KAFNQFSNLT THKKIHTGEQ PYICEECGKA FTQSSTLTTH KRIHTGEKPY KCEECGKAFN RSSKLTEHKN IHTGEQPYKC EECGKAFNRS SNLTEHRKIH TEEKPYKCKE CGKAFKHSSA LTTHKRIHTG EKPYKCEECG KAFNRSSKLT EHKKLHTGKK PYKCEECGKA FIQSSKLTEH KKIHSGEIPY KCEECGKAFK HSSSLTTHKR IHTGEKPYKC EECGKAFSRS SKLTEHKIIH TGEKPYKCER CDKAFNQSAN LTKHKKIHTG EKLQNWNV
Explore Zinc finger protein 675 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets